 |
|
|
||||||||
|
||||||||||
 |
||||||||||
 |
|||
|
|
|
|
|
Data sets for a FELASA Category C course on experimental design and statistics, Madrid, April 2010
Data set 1. 1-way ANOVA with outliers Micronucleus counts Control Urethane MCA 1.48 3.04 1.26 2.23 3.48 2.13 1.87 2.49 1.87 1.88 3.56 0.75 1.9 6.10 2.00 1.59 2.81 1.98 1.23 3.85 2.27 2.06 2.90 2.34 2.15 5.39 1.55 0.66 1.57 2.26 0.33 2.15 1.76 1.22 2.34 0.83
Data set 2 Platelet counts in groups of rats One-way ANOVA, unequal variances Platelet count in six groups of rats Group Count Ctrl 415 Ctrl 500 Ctrl 395 Ctrl 430 Ctrl 415 Ctrl 450 Ctrl 484 Ctrl 520 Ctrl 424 Ctrl 479 Vehicle 435 Vehicle 440 Vehicle 292 Vehicle 320 Vehicle 459 Vehicle 440 Vehicle 323 Vehicle 510 Vehicle 375 NER654 430 NER654 457 NER654 380 NER654 500 NER654 542 NER654 491 NER654 505 NER654 549 BBN 615 BBN 512 BBN 590 BBN 527 BBN 705 BBN 560 BBN 420 BBN 570 BBN 407 BBN 442 BBN 333 BBN 554 BBNNER 996 BBNNER 737 BBNNER 600 BBNNER 540 BBNNER 433 BBNNER 535 BBNNER 855 BBNNER 545 BBNNER 445 BBNNER 695 BBNNER 585 BBNNER 775 BBNNER 748 BBNNER2 705 BBNNER2 630 BBNNER2 490 BBNNER2 675 BBNNER2 603 BBNNER2 536 BBNNER2 485 BBNNER2 498 BBNNER2 532 BBNNER2 493 BBNNER2 557 BBNNER2 847
Data set 3. Regression analysis Lesion diameter in pigs Power Diameter 50 3.3 50 3.2 50 2.8 50 2.8 50 2.4 50 2.7 50 3.2 50 3.8 50 1.5 100 4.7 100 4.0 100 3.5 100 4.4 100 3.9 100 4.8 100 4.4 100 3.7 100 4.0 150 5.5 150 5.0 150 4.4 150 4.5 150 6.0 150 6.5 150 5.0 150 5.0 200 5.8 200 6.0
Data set 4. Randomised block Apoptosis
Apoptosis randomised block Week Trt apoptosis Wk1 1 365 Wk1 2 398 Wk1 3 421 Wk2 1 423 Wk2 2 432 Wk2 3 459 Wk3 1 308 Wk3 2 320 Wk3 3 329
Treatments 1=control 2=CGP 3=STAU
Data set 5. Rand. Block with replication Lab mutants Trt 1 11.8 Control 1 11.3 Control 2 10.3 Control 2 9.5 Control 3 6.5 Control 3 3.9 Control 4 5.4 Control 4 6.2 Control 5 14.2 Control 5 15.2 Control 1 18.8 L.Dose 1 20.6 L.Dose 2 16.8 L.Dose 2 13 L.Dose 3 2.4 L.Dose 3 3.9 L.Dose 4 11.7 L.Dose 4 11.6 L.Dose 5 21.2 L.Dose 5 13.7 L.Dose 1 16.4 H.Dose 1 23.4 H.Dose 2 13.2 H.Dose 2 14.6 H.Dose 3 8.4 H.Dose 3 8.6 H.Dose 4 12.4 H.Dose 4 12.2 H.Dose 5 22.5 H.Dose 5 15.8 H.Dose
Dataset 6 Taste preference
Percent Cage Treatment 54.9 1 Water 48.2 2 Water 49.9 3 Water 50.4 4 Water 69.6 1 Saccharin 61.1 2 Saccharin 58.2 3 Saccharin 55.3 4 Saccharin 61.9 1 Salt 43.9 2 Salt 53.4 3 Salt 50.7 4 Salt 78.3 1 Sucrose 81.5 2 Sucrose 74.7 3 Sucrose 73.6 4 Sucrose 69.4 1 Ethanol 60.9 2 Ethanol 68.5 3 Ethanol 64.5 4 Ethanol
Data set 7 Paired design Strain Treated Control A/J 22.8 21.8 A2G 24 23.2 BALB/c 22.3 21.5 CBA 20.6 20.5 C3H 24 23.9 C57BL/6 24.8 24.7 DBA/2 22.4 21.7 NIH 29.6 30
Data set 8 2x2 factorial no interaction Strain RBC Treatment BALB/c 10.1 Control BALB/c 10.08 Control BALB/c 9.73 Control BALB/c 10.09 Control C57BL 9.6 Control C57BL 9.56 Control C57BL 9.14 Control C57BL 9.2 Control BALB/c 8.95 Treated BALB/c 8.45 Treated BALB/c 8.68 Treated BALB/c 8.89 Treated C57BL 8.82 Treated C57BL 8.24 Treated C57BL 8.18 Treated C57BL 8.1 Treated
Dataset 9 2x2 factorial with interaction
Strain RBC Treatment C3H 7.85 Control C3H 8.77 Control C3H 8.48 Control C3H 8.22 Control CD-1 9.01 Control CD-1 7.76 Control CD-1 8.42 Control CD-1 8.83 Control C3H 7.81 Treated C3H 7.21 Treated C3H 6.96 Treated C3H 7.1 Treated CD-1 9.18 Treated CD-1 8.31 Treated CD-1 8.47 Treated CD-1 8.67 Treated
Data set 10 EROD Factorial randomised block Strain Treatment Block EROD A/J T 1 18.7 129/Ola T 1 17.9 NIH T 1 19.2 BALB/c T 1 26.3 A/J C 1 7.7 129/Ola C 1 8.4 NIH C 1 9.8 BALB/c C 1 9.7 A/J T 2 16.7 129/Ola T 2 14.4 NIH T 2 12 BALB/c T 2 19.8 A/J C 2 6.4 129/Ola C 2 6.7 NIH C 2 8.1 BALB/c C 2 6
Dataset 11 Tamoxifen
mRNA Treatment Strain 12.067 Control F344 2.992 Control F344 7.844 Control F344 3.356 Control Wistar 3.5 Control Wistar 5.64 Control Wistar 3.636 Control LEW 2.161 Control LEW 3.441 Control LEW 1.712 Tamoxifen F344 2.827 Tamoxifen F344 2.825 Tamoxifen F344 4.84 Tamoxifen Wistar 4.341 Tamoxifen Wistar 9.148 Tamoxifen Wistar 27.58 Tamoxifen LEW 19.7 Tamoxifen LEW 4.533 Tamoxifen LEW
az?aUY~S|_?/D?$? |
|||